Loading...
Market
What will be the impact of RFK Jr.'s investigation on pharma companies by end of 2025?
2
Resolution / Starting Odds
Significant negative impact • 25%
No significant impact • 25%
Positive impact • 25%
Investigation not concluded • 25%
Stock market reports, industry analyses, and official statements
Story
Trump Appoints RFK Jr. to Investigate Vaccines' Link to Autism as HHS Head, Emphasizing Legacy Focus
Dec 8, 2024, 02:47 PM
President Donald Trump announced that Robert F. Kennedy Jr. will lead an investigation as the head of the Department of Health and Human Services (HHS) into childhood vaccines and their potential link to autism, as well as other possible causes. During a press interaction, NBC's Kristen Welker questioned Trump on whether he intends to eliminate childhood vaccinations. Trump responded, stating that he would consider ending vaccinations if they are deemed dangerous for children. This initiative is part of Trump's broader agenda, which he views as a significant aspect of his legacy, positioning himself as a leader against the influence of pharmaceutical companies.
View original story
Similar markets
Supportive • 25%
Opposed • 25%
Neutral • 25%
Mixed • 25%
Launches public campaign • 25%
Engages in lobbying efforts • 25%
No significant response • 25%
Other actions • 25%
Full implementation • 25%
Partial implementation • 25%
No implementation • 25%
Reversal or cancellation • 25%
Confirms link • 25%
Inconclusive • 25%
Investigation incomplete • 25%
Vaccines linked to autism • 25%
Vaccines not linked to autism • 25%
Investigation not completed • 25%
No link found • 25%
Link found • 25%
Inconclusive results • 25%
No report released • 25%
More negative perception • 25%
More positive perception • 25%
No significant change • 25%
Other • 25%
Vaccines remain unchanged • 25%
Vaccines undergo major restrictions • 25%
New vaccine safety studies mandated • 25%
Other outcomes • 25%
Appointed and active • 25%
Appointed but inactive • 25%
Not appointed • 25%
Other outcome • 25%
Policy implemented • 25%
Policy blocked by courts • 25%
Policy withdrawn • 25%
No significant action taken • 25%
Complete overhaul as proposed • 25%
Partial implementation • 25%
No significant changes • 25%
Other unforeseen outcome • 25%
Increased vaccine skepticism • 25%
Decreased vaccine skepticism • 25%
No significant change • 25%
Insufficient data • 25%
Significant Increase • 25%
Moderate Increase • 25%
No Significant Change • 25%
Decrease • 25%